Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
Active, not recruiting · NCT03672773 · Registry updated 2025-11-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Active, not recruiting | Phase 2 | 2025-11-10 | NCT03672773 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 115 |
| Pfizer | 431 |
| Translational Research in Oncology | 9 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Center of Kansas | Wichita | United States | 21 |
| CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center | Bakersfield | United States | 1 |
| Ft. Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | United States | 2 |
| Orlando Health, Inc. d/b/a Orlando Health UF Health Center | Orlando | United States | 2 |
| St. Joseph Heritage Healthcare | Fullerton | United States | 2 |
| UCLA / Jonsson Comprehensive Cancer Center | Los Angeles | United States | 126 |